SE8902608L - Pyrrolidin- och piperidonfoereningar och farmaceutiska kompositioner innehaallande dessa - Google Patents

Pyrrolidin- och piperidonfoereningar och farmaceutiska kompositioner innehaallande dessa

Info

Publication number
SE8902608L
SE8902608L SE8902608A SE8902608A SE8902608L SE 8902608 L SE8902608 L SE 8902608L SE 8902608 A SE8902608 A SE 8902608A SE 8902608 A SE8902608 A SE 8902608A SE 8902608 L SE8902608 L SE 8902608L
Authority
SE
Sweden
Prior art keywords
compounds
pyrrolidin
piperido
pharmaceutical compositions
compositions containing
Prior art date
Application number
SE8902608A
Other languages
English (en)
Other versions
SE500670C2 (sv
SE8902608D0 (sv
Inventor
S J Lee
Original Assignee
Biofor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Ltd filed Critical Biofor Ltd
Publication of SE8902608D0 publication Critical patent/SE8902608D0/sv
Publication of SE8902608L publication Critical patent/SE8902608L/sv
Publication of SE500670C2 publication Critical patent/SE500670C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE8902608A 1988-09-26 1989-07-27 Pyrrolidin- och piperidonföreningar och farmaceutiska kompositioner innehållande dessa SE500670C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/248,942 US4959482A (en) 1988-09-26 1988-09-26 Pyrrolidinone compounds and pharamaceutical compositions containing same

Publications (3)

Publication Number Publication Date
SE8902608D0 SE8902608D0 (sv) 1989-07-27
SE8902608L true SE8902608L (sv) 1990-03-27
SE500670C2 SE500670C2 (sv) 1994-08-08

Family

ID=22941364

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902608A SE500670C2 (sv) 1988-09-26 1989-07-27 Pyrrolidin- och piperidonföreningar och farmaceutiska kompositioner innehållande dessa

Country Status (8)

Country Link
US (1) US4959482A (sv)
JP (1) JPH02129167A (sv)
AU (1) AU3893289A (sv)
BE (1) BE1003692A4 (sv)
DE (1) DE3932068A1 (sv)
FR (1) FR2636947B1 (sv)
GB (1) GB2223014B (sv)
SE (1) SE500670C2 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128330A (en) * 1991-02-19 1992-07-07 Biofor, Ltd. Oxazinone substituted phosphines
US5256091A (en) * 1991-11-06 1993-10-26 Outboard Marine Corporation Shift interlock system
JPH06504793A (ja) * 1991-11-15 1994-06-02 アメリカン・サイアナミド・カンパニー トリアジントリス−ラクタム架橋剤の製造方法および上記含有硬化性組成物
JP5205379B2 (ja) * 2006-08-09 2013-06-05 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー プロゲステロン受容体モジュレータとしてのピロリジノンアニリン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754141A (fr) * 1969-08-04 1971-02-01 Pfizer Esters d'alpha-carboxyarylmethyl penicillines
US3717659A (en) * 1970-06-09 1973-02-20 Merck & Co Inc Heterocyclic salicylic acid derivatives
US3718743A (en) * 1970-11-19 1973-02-27 Merck & Co Inc 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation
US3790597A (en) * 1971-04-12 1974-02-05 Ciba Geigy Corp Sulfur derivatives of alkylhydroxyphenyl maleimides and compositions thereof
US3906002A (en) * 1973-12-28 1975-09-16 John F Stephen Hindered phenolic norbornane-2,3-dicarboximides
US4124725A (en) * 1977-05-16 1978-11-07 Riker Laboratories, Inc. Anti-inflammatory method
US4172082A (en) * 1977-05-16 1979-10-23 Riker Laboratories, Inc. Substituted thiophenes
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
US4357345A (en) * 1981-11-23 1982-11-02 Riker Laboratories, Inc. Substituted furans
JPS5965071A (ja) * 1982-09-02 1984-04-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド 鎮痛、抗炎症剤
US4743606A (en) * 1986-03-25 1988-05-10 Boehringer Ingelheim Pharmaceuticals, Inc. 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties

Also Published As

Publication number Publication date
GB8920270D0 (en) 1989-10-18
US4959482A (en) 1990-09-25
BE1003692A4 (fr) 1992-05-26
GB2223014A (en) 1990-03-28
GB2223014B (en) 1992-03-18
JPH02129167A (ja) 1990-05-17
FR2636947A1 (fr) 1990-03-30
DE3932068A1 (de) 1990-03-29
SE500670C2 (sv) 1994-08-08
SE8902608D0 (sv) 1989-07-27
AU3893289A (en) 1990-03-29
FR2636947B1 (fr) 1994-10-28

Similar Documents

Publication Publication Date Title
SE8700499D0 (sv) Novel pharmacologically active compounds
SE8505112D0 (sv) Novel pharmacological compounds
IL76454A0 (en) Diarylacetylenes,their preparation and pharmaceutical compositions containing them
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ATE243196T1 (de) Piperidine und pyrrolidine
DK538888A (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
SE8404065D0 (sv) Novel biologically active compounds
NZ240575A (en) N-benzoylproline derivatives and pharmaceutical compositions
FR2674754B1 (fr) Composition medicamenteuse micronisee.
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
TW198685B (sv)
FI935064A (fi) Nya heterocykliska karboxylsyror
SE8902608L (sv) Pyrrolidin- och piperidonfoereningar och farmaceutiska kompositioner innehaallande dessa
DK192988A (da) Dihydropyridinamider, deres fremstilling og anvendelse
SE8600658D0 (sv) Novel composition of matter
IE880248L (en) 5-(3-Alkyl-5-tert¹butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazines, a¹process for the preparation thereof, medicaments containing¹same, and the use thereof
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
SE8902607L (sv) Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma
ATE44461T1 (de) Analgetische zusammensetzungen.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ES2039273T3 (es) Compuestos antimicoticos a base de combinaciones de nicomicina y azol antimicotico.
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
ZA917273B (en) Use of n-(1-hexahydroazepinylalkyl)acetamides in the preparation of medicaments for the treatment of cholinergic transmission disorders
DK72790D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse